glp 1 consent form Glp1 GLP1 Informed Consent

The central nervous system actions of GLP-1 receptor agonists contribute substantially to their clinical benefits but also account for common tolerability issues

GLP-1RAs thus prevent the occurrence of retinal damage associated with oxidative-stress-induced activation of glial cells and collectively foster a healthy retinal microenvironment by virtue of preventing cellular overexertion [94, 100]

Furthermore, other pathophysiological abnormalities [5], such as increased renal glucose re-absorption [6] and the diminished incretin effect [7] have been found to contribute to the hyperglycemia manifested by the disease

When examining the effects on glucose homeostasis, the results were mixed

The GLP-1 component reaches a threshold level that produces noticeable changes in hunger patterns and food preferences

A., & Sahebkar, A